Latest News
Selected early versions will be slated for real-world deployment.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
40% of their time is spent on manually collecting data, which the tool would assist in reducing.
